KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Common Equity (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Common Equity readings, the most recent being $8.2 billion for Q1 2026.

  • On a quarterly basis, Common Equity rose 31.31% to $8.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.2 billion, a 31.31% increase, with the full-year FY2025 number at $7.9 billion, up 47.1% from a year prior.
  • Common Equity hit $8.2 billion in Q1 2026 for Teva Pharmaceutical Industries, up from $7.9 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $10.3 billion in Q1 2022 to a low of $5.4 billion in Q4 2024.
  • Median Common Equity over the past 5 years was $7.6 billion (2023), compared with a mean of $7.8 billion.
  • Biggest five-year swings in Common Equity: crashed 33.79% in 2024 and later skyrocketed 47.1% in 2025.
  • Teva Pharmaceutical Industries' Common Equity stood at $8.6 billion in 2022, then dropped by 5.49% to $8.1 billion in 2023, then plummeted by 33.79% to $5.4 billion in 2024, then surged by 47.1% to $7.9 billion in 2025, then grew by 4.02% to $8.2 billion in 2026.
  • The last three reported values for Common Equity were $8.2 billion (Q1 2026), $7.9 billion (Q4 2025), and $7.3 billion (Q3 2025) per Business Quant data.